AcuCort AB (ACUC.ST)

SEK 0.65

(-3.25%)

Operating Expenses Summary of AcuCort AB

  • AcuCort AB's latest annual operating expenses in 2023 was 13.24 Million SEK , down -10.63% from previous year.
  • AcuCort AB's latest quarterly operating expenses in 2024 Q2 was 5.07 Million SEK , up 42.57% from previous quarter.
  • AcuCort AB reported a annual operating expenses of 14.82 Million SEK in annual operating expenses 2022, up 31.25% from previous year.
  • AcuCort AB reported a annual operating expenses of 11.29 Million SEK in annual operating expenses 2021, up 45.77% from previous year.
  • AcuCort AB reported a quarterly operating expenses of 5.07 Million SEK for 2024 Q2, up 42.57% from previous quarter.
  • AcuCort AB reported a quarterly operating expenses of 3.93 Million SEK for 2023 Q4, up 27.84% from previous quarter.

Annual Operating Expenses Chart of AcuCort AB (2023 - 2016)

Historical Annual Operating Expenses of AcuCort AB (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 13.24 Million SEK -10.63%
2022 14.82 Million SEK 31.25%
2021 11.29 Million SEK 45.77%
2020 7.74 Million SEK -7.43%
2019 8.37 Million SEK 34.54%
2018 6.22 Million SEK 33.26%
2017 4.66 Million SEK 143.2%
2016 1.91 Million SEK 0.0%

Peer Operating Expenses Comparison of AcuCort AB

Name Operating Expenses Operating Expenses Difference
AlzeCure Pharma AB (publ) 38.26 Million SEK 65.373%
BioGaia AB (publ) 507.08 Million SEK 97.387%
Enzymatica AB (publ) 79.92 Million SEK 83.423%
Enorama Pharma AB (publ) 38.22 Million SEK 65.34%
Gabather AB (publ) 9.47 Million SEK -39.846%
Klaria Pharma Holding AB (publ.) 14.88 Million SEK 10.985%
Moberg Pharma AB (publ) 27.46 Million SEK 51.757%
Nanexa AB (publ) 135.78 Million SEK 90.242%
Newbury Pharmaceuticals AB (publ) 30.11 Million SEK 55.999%
ODI Pharma AB -5.00 SEK 264980100.0%
Orexo AB (publ) 659.4 Million SEK 97.991%
Probi AB (publ) 208.93 Million SEK 93.659%
Swedencare AB (publ) 1.12 Billion SEK 98.825%
Swedish Orphan Biovitrum AB (publ) 9.39 Billion SEK 99.859%
Toleranzia AB 6.97 Million SEK -90.032%
Vivesto AB 355.71 Million SEK 96.275%